Dr. Rakesh Srivastava: The
Dr. Rakesh Srivastava
The President Dr. Rakesh Srivastava obtained his Ph.D. degree from the University of Guelph, Ontario, Canada, and MBA from Tulane University. He is a fellow of the Royal Society of Medicine, and Royal Society of Public Health, and a member of the American Association of Advancement of Sciences, and the American Association of Cancer Research. He has served as the President and CEO of GLax LLC. Dr. Srivastava has worked at the National Institutes of Health, USA. He was a fellow at the National Academy of Sciences, USA, and worked as a full professor at major Universities in the US. He has more than 40 years of experience in therapeutics, drug design and development, cell signaling, nutrition, toxicology, virology, diabetes, obesity, and cancer. He is recently involved in developing vaccines and treatments for COVID-19. He has been a consultant to major pharmaceutical companies, state and federal governments, and private organizations. He has published 150 high-impact scientific papers in peer-reviewed journals and presented 200 papers in national and international scientific meetings. He holds 8 patents in US, Canada, Europe, and India. He has edited six books on Apoptosis, Diabetes, Nutrition, Cancer, Health Disparities, Clinical Trials, and Government Policies in Medicine, and published 20 book chapters. He has brought several drugs e.g. Inhibitors of MAPK, PI3K, AKT, Smoothened, Gli, Histone Deacetylases, and COX-II to the clinics. He was involved in National Cancer Institute and Industry-sponsored clinical trials. His work has been recognized globally.
GLAX Health is involved in multidisciplinary roles as a global leader in the field of medical research and services, drug development, production and sales. It has taken an innovative approach for the treatment and prevention of human diseases such as Diabetes, Cancer, and Infectious Diseases (e.g. COVID-19). We conduct research in the areas of cancer, diabetes, neurological disorders an infectious disease. Through our dedicated scientists, clinicians and staff, we provide services to our clients in the field of drug development, clinical pharmacology, commercialization, clinical trial design, drug approval, and medical, clinical and regulatory support. We have established collaborations with government, pharmaceutical companies and private foundations. We provide services in the are of drug testing, protocol development, pharmacokinetics and pharmacodynamics and animal studies Our manufacturing department specializes in synthesis, production, sales and distribution of small molecules, natural products and antibodies for research and clinical use. Our talented and dedicated team of professionals provide state-of-the-art personalized medical research and clinical trial support.